These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18363819)

  • 21. Low frequency of elevated prothrombin times in patients with lupus anticoagulants when using a recombinant thromboplastin reagent: implications for dosing and monitoring of oral anticoagulant therapy.
    Moore GW; Rangarajan S; Holland LJ; Henley A; Savidge GF
    Br J Biomed Sci; 2005; 62(1):15-8; quiz 47. PubMed ID: 15816206
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificially depleted plasmas are not necessarily commutable with native patient plasmas for International Sensitivity Index calibration and International Normalized Ratio derivation.
    van den Besselaar AM
    J Thromb Haemost; 2012 Feb; 10(2):303-5. PubMed ID: 22136646
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of STA-NeoPTimal, an extraction thromboplastin reagent with ISI close to 1.
    Carta M; Bonente F; Teresa Comberlato M; Pellizzari T; Marotto E; Marzari E; Giavarina D
    Int J Lab Hematol; 2021 Apr; 43(2):311-317. PubMed ID: 33070473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Normalized Ratio in patients not on vitamin K antagonists.
    Keeling D
    J Thromb Haemost; 2007 Jan; 5(1):188-9. PubMed ID: 17067366
    [No Abstract]   [Full Text] [Related]  

  • 26. Thromboplastin calibration revisited to look for possible revision of the World Health Organization recommendations.
    Tripodi A; Scalambrino E; Clerici M; Chantarangkul V; Peyvandi F
    J Thromb Haemost; 2023 Feb; 21(2):311-316. PubMed ID: 36700497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phospholipid composition controls thromboplastin sensitivity to individual clotting factors.
    Smith SA; Comp PC; Morrissey JH
    J Thromb Haemost; 2006 Apr; 4(4):820-7. PubMed ID: 16634752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant lipoprotein-associated coagulation inhibitor inhibits tissue thromboplastin-induced intravascular coagulation in the rabbit.
    Day KC; Hoffman LC; Palmier MO; Kretzmer KK; Huang MD; Pyla EY; Spokas E; Broze GJ; Warren TG; Wun TC
    Blood; 1990 Oct; 76(8):1538-45. PubMed ID: 2207329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.
    Pfäfflin A
    Clin Chem Lab Med; 2009; 47(2):242-3. PubMed ID: 19191733
    [No Abstract]   [Full Text] [Related]  

  • 30. The calibration of rabbit tissue thromboplastins: experience of the Dutch Reference Laboratory for anticoagulant control.
    van den Besselaar AM; Hermans J; van der Velde EA; Bussemaker-Verduyn den Boer E; van Halem-Visser LP; Jansen-Grüter R; Loeliger EA
    J Biol Stand; 1986 Oct; 14(4):305-17. PubMed ID: 3558415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?
    Jackson CM; Esnouf MP
    Clin Chem; 2005 Mar; 51(3):483-5. PubMed ID: 15738512
    [No Abstract]   [Full Text] [Related]  

  • 32. The response of Quick's prothrombin time test to oral anticoagulation. Influence of thromboplastin source and calcium chloride concentration.
    van den Besselaar AM
    Arch Pathol Lab Med; 1994 Feb; 118(2):145-9. PubMed ID: 8311653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The challenge of regulating anticoagulant drugs: focus on warfarin.
    Mann KG
    Am Heart J; 2005 Jan; 149(1 Suppl):S36-42. PubMed ID: 15644792
    [No Abstract]   [Full Text] [Related]  

  • 34. A review of variables affecting PTs/INRs.
    McGlasson DL
    Clin Lab Sci; 1999; 12(6):353-8. PubMed ID: 10724633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the reaction temperature on the prothrombin time and the apparent International Normalized Ratio determined with International Standards for thromboplastins.
    Van Den Besselaar AMHP; Cobbaert CM
    Int J Lab Hematol; 2022 Apr; 44(2):379-384. PubMed ID: 34747561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of domestic thromboplastins with attested international indices of sensitivity in the treatment of thrombophilia].
    Kachalova ND; Klimovich LG; Berkovskiĭ AL; Prostakova TM; Kozlov AA
    Klin Lab Diagn; 2002 Jun; (6):13-6. PubMed ID: 12132368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of telavancin (Vibativ) on routine coagulation test results.
    Gosselin R; Dager W; Roberts A; Freeman L; Gandy L; Gregg J; Dwyre D
    Am J Clin Pathol; 2011 Dec; 136(6):848-54. PubMed ID: 22095369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A high-sensitivity thromboplastin reagent prepared from cultured human cells.
    Valdes-Camin R; Callahan JB; Ebert RF
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):617-24. PubMed ID: 7841320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.